Published in J Immunol on November 01, 1980
Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79
CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med (1998) 1.56
CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection. PLoS Negl Trop Dis (2011) 1.02
Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin. J Clin Invest (1989) 0.94
Enhanced pro-inflammatory cytokine responses following Toll-like-receptor ligation in Schistosoma haematobium-infected schoolchildren from rural Gabon. PLoS One (2011) 0.87
Suppression of immune response to Listeria monocytogenes: mechanism(s) of immune complex suppression. Infect Immun (1985) 0.85
Immunoregulation in experimental filariasis. IV. Induction of non-specific suppression following in vitro exposure of spleen cells from infected jirds to Brugia pahangi antigen. Immunology (1984) 0.85
Schistosoma mansoni egg granuloma size reduction in challenged baboons after vaccination with irradiated cryopreserved schistosomula. Proc Natl Acad Sci U S A (1984) 0.83
Failure of immunosuppressive mechanisms in human Schistosoma mansoni infection with hepatosplenomegaly. J Clin Microbiol (1987) 0.82
Evaluation of cellular immune response during chronic schistosomiasis in humans by the leukocyte aggregation test and the leukocyte migration inhibition test. J Clin Microbiol (1985) 0.80
Serosuppression in experimental filariasis. Clin Exp Immunol (1984) 0.80
Schistosoma japonicum egg antigen-specific T cell lines in man. Induction of helper and suppressor T cell lines and clones in vitro in a patient with chronic schistosomiasis japonica. J Clin Invest (1988) 0.75
Schistosoma mekongi infection in man: cellular immune responses and modulating mechanisms. Clin Exp Immunol (1982) 0.75
Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02
Averting a malaria disaster. Lancet (1999) 9.40
Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med (1970) 4.50
Giardiasis in the mouse: an animal model. Gastroenterology (1976) 4.47
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04
An in vitro assay for cellular hypersensitivity in man. J Immunol (1970) 3.73
Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development (1996) 3.63
Revisions to the National Health Accounts and methodology. Health Care Financ Rev (1990) 3.58
Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med (1974) 3.38
International reference preparation of rheumatoid arthritis serum. Bull World Health Organ (1970) 3.36
M-antiglobulins (rheumatoid-factor-like globulins) and other gamma-globulins in relation to tropical parasitic infections. Lancet (1966) 3.31
Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature (1975) 2.92
Models to predict the intensity of Plasmodium falciparum transmission: applications to the burden of disease in Kenya. Trans R Soc Trop Med Hyg (1999) 2.82
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81
Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol (1975) 2.59
Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF). J Immunol (1974) 2.53
Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med (1978) 2.50
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol (1992) 2.33
The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23
A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19
Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am J Pathol (1968) 2.18
The compartmentalization of antigen-reactive lymphocytes in desensitized guinea pigs. J Exp Med (1971) 2.18
Heterophile antibodies, M-antiglobulins and immunoglobulins in experimental trypanosomiasis. Clin Exp Immunol (1969) 2.16
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils. J Exp Med (1977) 2.06
The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol (1966) 2.03
Mediators of immunity: lymphokines and monokines. Adv Immunol (1980) 1.99
HIV, malaria parasites, and acute febrile episodes in Ugandan adults: a case-control study. AIDS (2001) 1.98
Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. J Clin Invest (1976) 1.95
Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis (2009) 1.92
The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg (1972) 1.91
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish. Development (1997) 1.84
Production of migration inhibitory factor by non-dividing lymphocytes. J Immunol (1973) 1.82
Dispersion of papers among journals based on a mathematical analysis of two diverse medical literatures. Nature (1969) 1.79
Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis (2011) 1.74
Antibody-dependent cell-mediated damage to schistosomula in vitro. Nature (1974) 1.72
Acquired resistance to infection in an animal model of giardiasis. J Immunol (1976) 1.70
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68
Correlated changes of some enzyme activities and cofactor and substrate contents of pea cotyledon tissue during germination. Biochem J (1968) 1.67
Mapping malaria transmission intensity using geographical information systems (GIS): an example from Kenya. Ann Trop Med Parasitol (1998) 1.65
Cell-mediated damage to helminths. Adv Parasitol (1984) 1.64
Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol (1970) 1.64
In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J Clin Invest (1997) 1.64
Characterization of human migration inhibitory factor (MIF) from antigen-stimulated lymphocytes. Cell Immunol (1972) 1.63
Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61
Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg (1985) 1.58
The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58
Granuloma formation around Schistosoma mansoni, S. HAEMATOBIUM, AND S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg (1970) 1.56
Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children. Lancet (1972) 1.52
Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol (2003) 1.51
Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med (1980) 1.50
Immunity to schistosomes: progress toward vaccine. Science (1987) 1.49
Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. J Infect Dis (1999) 1.48
Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis (1973) 1.47
High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol (1998) 1.47
The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. N Engl J Med (1971) 1.47
Secretory IgA against enterotoxins in breast-milk. Lancet (1976) 1.47
The mechansim of antibody-dependent, eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro: a study by phase-contrast and electron microscopy. J Cell Sci (1978) 1.46
Situation analysis of malaria in school-aged children in Kenya - what can be done? Parasitol Today (2000) 1.46
Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun (1993) 1.46
Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. Int J Tuberc Lung Dis (2009) 1.46
Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology (1999) 1.45
The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma. J Exp Med (1970) 1.44
A functional classification of granulomatous inflammation. Ann N Y Acad Sci (1976) 1.44
An application of the Kermack-McKendrick theory to the epidemiology of schistosomiasis. Am J Trop Med Hyg (1970) 1.43
Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg (1980) 1.43
A new method for measuring eosinophil activating factors, based on the increased expression of CR3 alpha chain (CD11b) on the surface of activated eosinophils. J Immunol Methods (1990) 1.42
Immunologic components of hypersensitivity reactions to cromolyn sodium. N Engl J Med (1975) 1.42
Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A. Infect Immun (1976) 1.42
Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest (1976) 1.41
Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med (1980) 1.40
Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. J Immunol (1989) 1.39
Immune complexes in the nephrotic syndrome of African children. Lancet (1969) 1.39
Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg (1988) 1.38
Selectivity of proteinuria and response to prednisolone or immunosuppressive drugs in children with malarial nephrosis. Lancet (1970) 1.38
Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol (1977) 1.37
A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: innate protection by antiproteases. J Exp Med (1995) 1.36
In vitro lymphocyte response of patients with immunologic deficiency diseases. N Engl J Med (1970) 1.34
Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro. J Exp Med (1983) 1.34
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med (1979) 1.34
Hepatosplenic schistosomiasis mansoni: an immunologic disease. Bull N Y Acad Med (1975) 1.34
Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans R Soc Trop Med Hyg (2004) 1.33
Histamine-induced suppressor factor (HSF): further studies on the nature of the stimulus and the cell which produces it. Cell Immunol (1979) 1.33
A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man. Parasitology (1995) 1.33
In vitro evidence for cellular hypersensitivity to glomerular-basement-membrane antigens in human glomerulonephritis. N Engl J Med (1970) 1.33